Cargando…
A Report of Three Girls with Antithyroid Drug-Induced Agranulocytosis; Retrospective Analysis of 18 Cases Aged 15 Years or Younger Reported between 1995 and 2009
Agranulocytosis is an extremely serious, although rare, adverse effect of antithyroid drugs (ATDs), including methimazole (MMI) and propylthiouracil (PTU), in children and adolescents. There are few reports about the characteristics of ATD-induced agranulocytosis in Japanese children and adolescents...
Autores principales: | Minamitani, Kanshi, Oikawa, Junko, Wataki, Kunio, Kashima, Kyoko, Hoshi, Mari, Inomata, Hiroaki, Ota, Setsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687635/ https://www.ncbi.nlm.nih.gov/pubmed/23926393 http://dx.doi.org/10.1297/cpe.20.39 |
Ejemplares similares
-
Antithyroid Drug-Induced Agranulocytosis: A Case Report
por: MacKay, Micaela, et al.
Publicado: (2023) -
Antithyroid drugs induced agranulocytosis and multiple myeloma:
case report and general considerations
por: Dănciulescu Miulescu, R, et al.
Publicado: (2013) -
Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management
por: Vicente, Nuno, et al.
Publicado: (2017) -
Antithyroid drug induced agranulocytosis: what still we need to learn ?
por: Chaudhry, Liaqat Ali, et al.
Publicado: (2016) -
Erratum: antithyroid drug induced agranulocytosis: what still we need to learn?
Publicado: (2016)